Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained release intraocular implants and methods for treating ocular vasculopathies

Sustained release intraocular implants and methods for treating ocular vasculopathies

US Patent 8580292 · Granted Nov 12, 2013

Estimated economic value: $39,474,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Liquid depot for non-invasive sustained delivery of agents to the eye2025
Liquid depot for non-invasive sustained delivery of agents to the eye2025
Bioerodible cross-linked hydrogel implants and related methods of use2024
Rho kinase inhibitor releasing implants and related methods of use2024
Bioerodible polyester polymer axitinib ocular implants and related methods of us2024
Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced to2023
Eye drop formulation and method for sustained delivery of medicament to the reti2022
Bioerodible cross-linked hydrogel implants and related methods of use2022
Liquid depot for non-invasive sustained delivery of agents to the eye2022
Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced t2021
High viscosity macromolecular compositions for treating ocular conditions2021
Microneedle array with active ingredient2021